Rishabh Mehreja, dRx Capital – Board Observer

Rishabh Mehreja

Rishabh is a Managing Director at dRx Capital, Novartis where he drives health-tech investments across the pharma value chain. Rishabh has deep experience in life sciences from his 17 years in the industry. Prior to dRx, Rishabh led digital innovation and tech-focused partnerships for Novartis, including those with Mayo Clinic, Doximity, and others. Previously, he led strategy and commercial execution for Novartis’ ~$8 Bn innovative medicines business in the US. Earlier in his career, Rishabh spent time with Bristol Myers Squibb’s US & Global oncology businesses. Rishabh holds an MBA from London Business School, a Master’s from Princeton where he spent 2 years as a PhD candidate in synthetic biology, and an engineering degree from IIT Bombay, India.

Rishabh is a board observer at Cleerly Health, RxVantage, Cala Health, Flywheel, Peptone, Freenome, and Aspen RxHealth. He is based out of East Hanover, New Jersey.

Verified by MonsterInsights